• 提示：詳情請下載說明書。

• 產(chǎn)品描述： LY 344864 is a selective, orally active 5-HT1F receptor agonist with a Ki of 6 nM. LY 344864 is a full agonist producing an effect similar in magnitude to serotonin itself. LY 344864 can cross the blood brain barrier to some extent

• 靶點： human 5-HT1F Receptor：0.006 μM (Ki)；human 5-HT1A Receptor：0.530 μM (Ki)；human 5-HT1B Receptor：0.549 μM (Ki)；human 5-HT1D Receptor：0.575 μM (Ki)；human 5-HT1E Receptor：1.415 μM (Ki)；human 5-HT2B Receptor：1.695 μM (Ki)；Human 5-HT2A Receptor：3.499 μM (Ki)；Human 5-HT3A Receptor：3.935 mM (Ki)；Human 5-HT7 Receptor：4.851 μM (Ki)；rat α2-adrenergic receptor：3.69 μM (Ki)；rat α1-adrenergic receptor：5.06 μM (Ki)

• 體內(nèi)研究：
  LY 344864 (0-10 ng/kg; p.o. or i.v.; once) inhibits neurogenic dural inflammation in rat migraine pain model. LY 344864 (1 mg/kg; i.v.; once) can cross the blood brain barrier to some extent in rats. LY 344864 (2 mg/kg; i.p.; daily for 14 days) attenuates dopaminergic neuron loss and improved behavioral endpoints in a Parkinson’s disease mouse model

• 參考文獻：
  1. Phebus LA, Johnson KW, Zgombick JM, Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brainpenetration and activity in the neurogenic dural inflammation model of migraine. Life Sci. 1997;61(21):2117-26. 2. Scholpa NE, et al. 5-HT1F receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease. Br J Pharmacol. 2018 Jan;175(2):348-358.

• 溶解性： Soluble  in  DMSO

• 保存條件： RT

• 配置溶液濃度參考：
  

  	1mg	5mg	10mg
  1 mM	2.578 ml	12.891 ml	25.781 ml
  5 mM	0.516 ml	2.578 ml	5.156 ml
  10 mM	0.258 ml	1.289 ml	2.578 ml
  50 mM	0.052 ml	0.258 ml	0.516 ml

• 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

輸入產(chǎn)品批號：

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關系，公式為：

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *